Affect recognition deficits in schizophrenia: neural substrates and psychopharmacological implications.
Impaired emotional functioning is a prominent feature of schizophrenia that includes significant deficits in the ability to accurately recognize facial expressions of emotion. Recent work demonstrates that deficits in affect perception are related to functional outcome and negative symptoms, suggesting that remediation of these deficits may contribute to symptomatic and functional improvements. Thus far, antipsychotic drug treatments appear to be relatively ineffective as a remedial tool. However, investigations into the neurobiology of affective dysfunction show abnormal amygdala activation in schizophrenia during affect recognition tasks. Such findings indicate that regulation of amygdala responses may aid in more accurate emotion processing. Both serotonergic and anxiolytic GABAergic agents that modulate activation of the limbic system offer promising avenues for remediation efforts.
Pinkham
Amy E
AE
University of Pennsylvania Medical Center, Department of Psychiatry, 10th Floor Gates Building, Philadelphia, PA 19104, USA. amypi@bbl.med.upenn.edu
Gur
Raquel E
RE
Gur
Ruben C
RC
D000339:Affect; D000679:Amygdala / Q000000981:diagnostic imaging / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D006801:Humans; D019964:Mood Disorders / Q000188:drug therapy; D009433:Neural Inhibition; D018377:Neurotransmitter Agents / Q000378:metabolism; D010468:Perceptual Disorders / Q000188:drug therapy; D049268:Positron-Emission Tomography; D011600:Psychopharmacology / Q000379:methods; D021641:Recognition, Psychology; D012559:Schizophrenia / Q000175:diagnosis / Q000503:physiopathology; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D018377:Neurotransmitter Agents